Patents by Inventor Farid Dorkoosh

Farid Dorkoosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070293479
    Abstract: An olanzapine pharmaceutical composition is formed using anhydrous calcium hydrogen phosphate. The composition can be tabletted by dry processes and typically has good stability.
    Type: Application
    Filed: May 18, 2007
    Publication date: December 20, 2007
    Inventors: Niels Osinga, Farid Dorkoosh
  • Publication number: 20070269514
    Abstract: The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene oxide (substance with the appropriate plasticity and binding force) and wherein at least the above-mentioned specific size controlling agent is uniformly dispersed in the above-mentioned polyethylene oxide, a controlled-release pharmaceutical composition containing this sized product, and a method of manufacturing a controlled-release pharmaceutical composition containing this sized product. A controlled-release pharmaceutical composition with good uniformity of content can be presented by using powder particles of polyethylene oxide with powder properties suitable for tableting, which is obtained by uniform dispersion of the specific size controlling agent for polyethylene oxide of the present invention.
    Type: Application
    Filed: May 17, 2007
    Publication date: November 22, 2007
    Inventors: Korinde Jansen, Farid Dorkoosh
  • Publication number: 20070166380
    Abstract: A zolpidem tablet having modified release is designed as a tablet-in-tablet dosage form.
    Type: Application
    Filed: November 20, 2006
    Publication date: July 19, 2007
    Inventors: Frans van Dalen, Korinde Jansen, Farid Dorkoosh
  • Publication number: 20060257471
    Abstract: Crystalline aripiprazole Type II can be formulated into pharmaceutical tablets having reduced dissolution profile variability upon storage.
    Type: Application
    Filed: March 17, 2006
    Publication date: November 16, 2006
    Inventors: Gerrit Ettema, Raymond Westheim, Faysal Kalmoua, Korinde Jansen, Farid Dorkoosh